Analysis for CLX
- π Growth β 6/30
- π° Profitability β 14/20
- π¦ Financial Health β 12/20
- π΅ Valuation β 10/20
- β οΈ Risk β 7/10
Summary:
π Growth & Financial Trajectory
Across the 7 available quarters (partial view of an 8-quarter cycle), CLX's Revenues ranged roughly $1.66Bβ$1.79B with a notable spike in 2025 Q4. Net income fluctuated from about $80M to $336M, yielding a modest growth path that ends below the early-quarter level. The late-2025 period shows the strongest profitability, while 2026 data hint at a softer start before a later rebound. Overall, revenue trended flat to down slightly from start to end.
π° Margins & Cash Flow
Gross margin stayed solid, about 41%β51%, with better leverage in the strongest quarters. Operating leverage appears moderate; SG&A and benefits costs run as a sizable fixed share of revenue. Net cash flow from operating activities remained positive, typically in the $180β$311M range, while investing cash flow was modestly negative and financing activity cash flows were volatile, producing uneven free cash flow.
π‘οΈ Balance Sheet & Liquidity
Total assets sit around $5.5β7.8B, with liabilities broadly in line (~$5.3β5.6B). Equity to the parent has been variable and sometimes negative, and longβterm debt has been elevated (roughly $2.5β4.0B). Despite this, operating cash flow supports liquidity, aided by noncontrolling interest in several periods.
β οΈ Key Drivers & Risks
- Drivers: steady consumer-staple demand; brand/mix optimization
- Risks: earnings volatility; leverage sensitivity and cost inflation